Carcinogenesis -- Genetic aspects. : Regulation of carcinogenesis, angiogenesis and metastasis by the proprotein convertases (PCs) : a new potential strategy in cancer therapy / edited by A-Majid Khatib
Tests to experimentally measure the tumor-producing/cancer cell-producing potency of an agent by administering the agent (e.g., benzanthracenes) and observing the quantity of tumors or the cell transformation developed over a given period of time. The carcinogenicity value is usually measured as milligrams of agent administered per tumor developed. Though this test differs from the DNA-repair and bacterial microsome MUTAGENICITY TESTS, researchers often attempt to correlate the finding of carcinogenicity values and mutagenicity values
Tests to experimentally measure the tumor-producing/cancer cell-producing potency of an agent by administering the agent (e.g., benzanthracenes) and observing the quantity of tumors or the cell transformation developed over a given period of time. The carcinogenicity value is usually measured as milligrams of agent administered per tumor developed. Though this test differs from the DNA-repair and bacterial microsome MUTAGENICITY TESTS, researchers often attempt to correlate the finding of carcinogenicity values and mutagenicity values
Tests to experimentally measure the tumor-producing/cancer cell-producing potency of an agent by administering the agent (e.g., benzanthracenes) and observing the quantity of tumors or the cell transformation developed over a given period of time. The carcinogenicity value is usually measured as milligrams of agent administered per tumor developed. Though this test differs from the DNA-repair and bacterial microsome MUTAGENICITY TESTS, researchers often attempt to correlate the finding of carcinogenicity values and mutagenicity values
Tests to experimentally measure the tumor-producing/cancer cell-producing potency of an agent by administering the agent (e.g., benzanthracenes) and observing the quantity of tumors or the cell transformation developed over a given period of time. The carcinogenicity value is usually measured as milligrams of agent administered per tumor developed. Though this test differs from the DNA-repair and bacterial microsome MUTAGENICITY TESTS, researchers often attempt to correlate the finding of carcinogenicity values and mutagenicity values
Tests to experimentally measure the tumor-producing/cancer cell-producing potency of an agent by administering the agent (e.g., benzanthracenes) and observing the quantity of tumors or the cell transformation developed over a given period of time. The carcinogenicity value is usually measured as milligrams of agent administered per tumor developed. Though this test differs from the DNA-repair and bacterial microsome MUTAGENICITY TESTS, researchers often attempt to correlate the finding of carcinogenicity values and mutagenicity values
Tests to experimentally measure the tumor-producing/cancer cell-producing potency of an agent by administering the agent (e.g., benzanthracenes) and observing the quantity of tumors or the cell transformation developed over a given period of time. The carcinogenicity value is usually measured as milligrams of agent administered per tumor developed. Though this test differs from the DNA-repair and bacterial microsome MUTAGENICITY TESTS, researchers often attempt to correlate the finding of carcinogenicity values and mutagenicity values
1
Carcinogenicity : Overall evaluations of carcinogenicity : an updating of IARC monographs volumes 1 to 42 : this publication represents the views and expert opinions of an IARC ad-hoc Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 10-18 March 1987
Arsenic -- Carcinogenicity -- Congresses. : Human exposure to arsenic and other potentially toxic metals in some waters : the effect of leaching from rocks into surrounding waters / Admu Usman Mohammed
Dapsone -- Carcinogenicity. : Dapsone exposure and Australian Vietnam service : mortality and cancer incidence / [E J Wilson, K W Horsley, R. van der Hoek]
2007
1
Dioxins -- Carcinogenicity. : Health risks from dioxin and related compounds : evaluation of the EPA reassessment / Committee on EPA's Exposure and Human Health Reassessment of TCDD and Related Compounds, Board on Environmental Studies and Toxicology, Division on Earth and Life Studies, National Research Council of the National Academies
Hormones, Sex -- Carcinogenicity. : Advances in rapid sex-steroid action : new challenges and new chances in breast and prostate cancers / Gabriella Castoria, Antimo Migliaccio, editors
Pesticides -- Carcinogenicity. : Carcinogenicity and pesticides : principles, issues, and relationships / Nancy N. Ragsdale, editor, Robert E. Menzer, editor
Radiographic contrast media -- Carcinogenicity. : Liver cancer risk from internally-deposited radionuclides : recommendation of the National Council on Radiation Protection and Measurements
Tests to experimentally measure the tumor-producing/cancer cell-producing potency of an agent by administering the agent (e.g., benzanthracenes) and observing the quantity of tumors or the cell transformation developed over a given period of time. The carcinogenicity value is usually measured as milligrams of agent administered per tumor developed. Though this test differs from the DNA-repair and bacterial microsome MUTAGENICITY TESTS, researchers often attempt to correlate the finding of carcinogenicity values and mutagenicity values
Carcinogenicity testing -- Evaluation -- Congresses. : Long-term and short-term screening assays for carcinogens : a critical appraisal : reports of IARC ad hoc Working Groups which met in Hanover, F.R.G., 7-9 June, 1979, at a meeting organized by the Medizinische Hochschule Hanover, the Commission of the European Communities and the IARC
